Enrique Conterno

Track

Insider profile

Currently holds a position at FibroGen Inc

Performance

Overall performance
2.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 98% 68% 82%
Transactions
9 22% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -42%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director FibroGen Inc Jan. 6, 2020 -
Senior Vice President and President - Lilly Diabetes and President - Lilly USA Eli Lilly and Co Feb. 1, 2017 - Dec. 31, 2019
Senior Vice President and President - Lilly Diabetes Eli Lilly and Co Nov. 1, 2009 - Feb. 1, 2017
Enrique Conterno's trades of FibroGen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
433.15
Quantity 75,641 +6.2%
Value US$2,167,030
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
334.10
Quantity 68,167 -7.5%
Value US$3,408,887
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
195.97
Quantity 71,639 +27.0%
Value US$1,251,349
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
19.52
Quantity 1,869 -0.5%
Value US$36,483
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 19,486 -4.8%
Value US$393,565
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 12,103 -2.9%
Value US$244,448
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
21.16
Quantity 24,672 -6.5%
Value US$521,958
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
19.95
Quantity 1,538 -0.5%
Value US$30,683
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
15.79
Quantity 2,543 -0.8%
Value US$40,154
US FibroGen Inc (FGEN)
Transaction date
Purchase
Price
35.28
Quantity 19,800 +247.5%
Value US$698,599
US FibroGen Inc (FGEN)
Transaction date
Purchase
Price
36.29
Quantity 8,000 +inf%
Value US$290,282
Transaction date
Planned sale
Price
121.00
Quantity 25,000 -15.8%
Value US$3,025,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-10 2023-07-07
US FibroGen Inc (FGEN)
S Sale
75,641 +6.2%
433.15
US$2,167,030 		75,641 +6.2% 433.15 US$2,167,030
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
S Sale
68,167 -7.5%
334.10
US$3,408,887 		68,167 -7.5% 334.10 US$3,408,887
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
PlS Planned sale
71,639 +27.0%
195.97
US$1,251,349 		71,639 +27.0% 195.97 US$1,251,349
2023-04-11 2023-04-10
US FibroGen Inc (FGEN)
S Sale
1,869 -0.5%
19.52
US$36,483 		1,869 -0.5% 19.52 US$36,483
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
19,486 -4.8%
20.20
US$393,565 		19,486 -4.8% 20.20 US$393,565
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
12,103 -2.9%
20.20
US$244,448 		12,103 -2.9% 20.20 US$244,448
2023-03-10 2023-03-08
US FibroGen Inc (FGEN)
S Sale
24,672 -6.5%
21.16
US$521,958 		24,672 -6.5% 21.16 US$521,958
2023-01-10 2023-01-06
US FibroGen Inc (FGEN)
PlS Planned sale
1,538 -0.5%
19.95
US$30,683 		1,538 -0.5% 19.95 US$30,683
2022-12-09 2022-12-08
US FibroGen Inc (FGEN)
S Sale
2,543 -0.8%
15.79
US$40,154 		2,543 -0.8% 15.79 US$40,154
2020-06-12 2020-06-11
US FibroGen Inc (FGEN)
B Purchase
19,800 +247.5%
35.28
US$698,599 		19,800 +247.5% 35.28 US$698,599
2020-06-12 2020-06-10
US FibroGen Inc (FGEN)
B Purchase
8,000 +inf%
36.29
US$290,282 		8,000 +inf% 36.29 US$290,282
2019-02-20 2019-02-15
PlS Planned sale
25,000 -15.8%
121.00
US$3,025,000 		25,000 -15.8% 121.00 US$3,025,000